Company profile

BostonGene

BostonGene has raised a total of $386 million in funding across two rounds: a $150 million Series A in August 2020, led by SoftBank Vision Fund 2, and a $200 million Series B in November 2024, led by Eldridge and Tiger Global Management. Founded in 2015 and headquartered in Waltham, Massachusetts, BostonGene develops an AI-powered molecular and immune profiling platform that transforms cancer diagnostics and treatment. With a valuation of $1 billion (as of April 2022), the company continues to advance precision oncology through genomics, analytics, and artificial intelligence.

Back to profiles

Quick facts

Total funding: $386 million
Valuation: $1 billion
Founded: 2015
Headquarters: Waltham, Massachusetts, BostonGene develops an AI-powered molecular and immune profiling platform that transforms cancer diagnostics and treatment

Notable investors

SoftBank Vision Fund 2
Tiger Global Management

Reach buyers like BostonGene on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like BostonGene
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like BostonGene.

The 14-day trial ships every feature, no card required.

Start free →